NCT03256630View on ClinicalTrials.gov

Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate Cancer

TerminatedOBSERVATIONAL
Enrollment

128

Participants

Timeline

Start Date

January 10, 2018

Primary Completion Date

December 20, 2018

Study Completion Date

February 28, 2019

Conditions
Prostate Cancer
Trial Locations (1)

34747

Florida Hospital Global Robotics Institute, Celebration

Sponsors

Collaborators (1)

AdventHealth
All Listed Sponsors
collaborator

AdventHealth

OTHER

lead

Genomic Health®, Inc.

INDUSTRY